VTGN: Total Utang marang Modal VistaGen Therapeutics Inc
Vistagen Therapeutics (VTGN) is implementing eco-friendly closed-loop water consumption cycles to minimize environmental impact. The share price retrospective on GURU.Markets shows that the individual debt-to-equity ratio is 0.03. Financial stability is based on patents for the creation of fast-acting anxiety sprays, while the operating model relies on the full outsourcing of production and testing to external contractors.
%20-%20Utang%20marang%20Modal&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_VTGN_-_Vistagen-Therapeutics_-_Debt-to-Capital "Rasio Total Utang marang Ekuitas: Vistagen (VTGN) kanggo 04.07.2022 - 01.11.2026 | 👁️GURU.Markets👁️")
Rincian metrik lan analitis perusahaan Vistagen (VTGN)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Vistagen Therapeutics|VTGN - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas VistaGen Therapeutics, Inc.|VTGN - Utang perusahaan|Utang-utang marang kapitalisasi buku Vistagen|VTGN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Vistagen|Indikator likuiditas cepet vistagen.com
- statistik bathi lan rasio pasar:
Ringkesan analisis perusahaan:Vistagen Therapeutics, VTGN
To identify fundamental benchmarks in Vistagen Therapeutics (VTGN) financial statements, it is critical to evaluate the financing structure via the total liabilities-to-equity ratio. Analyzing the total debt-to-equity chart allows for a determination of the leverage level of this neuropharmacological innovator, revealing whether the debt load hinders investments in the development of safe, next-generation drugs for the treatment of anxiety disorders.
Analisis pesaing
Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Rasio Total Utang marang Ekuitas HRMY|Utang marang Ekuitas BHVN|Total Utang marang Modal AMLX|Koefisien Total Utang marang Modal Trevi Therapeutics Inc|Utang marang Ekuitas Praxis Medicines PRAX|Koefisien Total Utang marang Modal Anavex Life Sciences Corp (AVXL)|CBLL: Rasio Total Utang marang Ekuitas|Prothena Corporation PLC - Utang Agregat marang Modal|ALEC: Total Utang marang Modal|Annexon Biosciences (ANNX) - Total Utang marang Modal|OMER (Omeros Corp) - Total Utang marang Modal|NGNE - Rasio Utang marang Modal|Total Utang marang Modal ACIU|VYGR - Utang marang Modal|Utang marang Ekuitas Neumora Therapeutics, Inc. NMRA|SCLX: Rasio Utang marang Ekuitas|TVGN: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACOG (Alpha Cognition)|CGTX (Cognition Therapeutics) - Rasio Total Utang marang Ekuitas|IKT: Utang Agregat marang Modal|SAVA (Cassava Sciences) - Total Utang marang Modal|ASRT: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal COYA|OVID - Utang marang Modal|Utang marang Ekuitas Acumen Pharmaceuticals ABOS|Rasio Kabeh Utang marang Dana Pribadi CRVO|Alterity Therapeutics Ltd - Total Utang marang Modal|CLNN - Total Utang marang Modal|pepgen.com (PEPG) - Utang marang Ekuitas|Utang Agregat marang Ekuitas JUNS (Jupiter Neurosciences, Inc.)|RLMD (Relmada Therapeutics) - Total Utang marang Modal|Utang marang Modal annovisbio.com ANVS|Rasio Total Utang marang Ekuitas GRCE (Grace Therapeutics, Inc.)|Total Utang marang Modal Firefly Neuroscience, Inc. (AIFF)|Klotho Neurosciences - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal NRSN (NeuroSense Therapeutics Ltd)|Reviva Pharmaceuticals - Total Utang marang Modal|Koefisien Total Utang marang Modal MetaVia Inc MTVA|NRXS: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Helius Medical Technologies|Utang marang Ekuitas Passage Bio Inc.|Neuphoria (NEUP) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|Utang marang Ekuitas ATHA (athira.com)|Addex Therapeutics Ltd - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal ALZN (Alzamend Neuro Inc.)|Cyclerion - Total Utang marang Modal|Rasio Utang marang Modal Protagenic Therapeutics (PTIX)|pasitheaclinics.com (KTTA) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CRGT|Utang marang Ekuitas Avenue Therapeutics, Inc.|Rasio Utang marang Ekuitas BCLI (Brainstorm Cell Therapeutics Inc.)|Total Utang marang Modal CARA|CHRO - Utang marang Modal|Eliem Therapeutics Inc. - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Intra-Cellular Therapies Inc. ITCI|LBPH - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MRNS (Marinus Pharmaceuticals Inc)|NKGen (NKGN) - Utang marang Ekuitas|Utang marang Modal NeuroBo Pharma (NRBO)|Rasio Total Utang marang Ekuitas SAGE|Utang marang Ekuitas SNPX|Total Utang marang Modal TRVN|Koefisien Total Utang marang Modal vigilneuro.com|Utang marang Ekuitas Anew Medical WENA|Koefisien Total Utang marang Modal Cerevel Corp (CERE)